Abstract
Literature about COVID‐19 infections in patients with chronic inflammatory (skin) diseases treated with or without systemic therapy is scarce and controversial.1‐6 Therefore, we aimed to investigate the incidence and clinical course of COVID‐19 related symptoms and the effect on clinical and psychological symptoms in patients with atopic dermatitis (AD) and psoriasis vulgaris (PsO).